PROM1 and non-small cell lung carcinoma: In addition, a previous study revealed that CD133, a reliable biomarker for identifying CSCs in NPC30, showed comparably low expression levels in both 5T4hi and 5T4low cell populations in non-small cell lung cancer (NSCLC)22.